Picton Mahoney Asset Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Picton Mahoney Asset Management’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-150,000	Closed	-$1.54M	–	575
2023 Q1	$1.54M	Hold	150,000	–	–	0.07%	260
2022 Q4	$1.51M	Hold	150,000	–	–	0.07%	344
2022 Q3	$1.48M	Hold	150,000	–	–	0.05%	399
2022 Q2	$1.46M	Hold	150,000	–	–	0.06%	491
2022 Q1	$1.46M	Hold	150,000	–	–	0.05%	508
2021 Q4	$1.46M	Hold	150,000	–	–	0.04%	500
2021 Q3	$1.47M	Buy	+150,000	New	+$1.46M	0.05%	441

Picton Mahoney Asset Management's ORIA Position: Q2 2023 in Review

Picton Mahoney Asset Management sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 150,000 shares — an estimated $1.54M sold.

Picton Mahoney Asset Management first reported a position in ORIA in Q3 2021 and held it in 7 quarters. The position peaked at $1.54M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Picton Mahoney Asset Management reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Picton Mahoney Asset Management sold 150,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $1.54M.
Picton Mahoney Asset Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 7 quarters.
Picton Mahoney Asset Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $1.54M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2023, filed 3 Aug 2023.